National Pancreas Foundation is a 501(c)(3) organization, classified under Medical Research (NTEE H40). Contributions are tax-deductible.
3 Bethesda Metro Ctr Ste 700, Bethesda, MD 20814-6300
Among the 7 scored medical research organizations in Bethesda, National Pancreas Foundation holds 0.6 months of operating reserves (peer median 3.5 months), runs a typical yearly deficit of 14.9% (peers: surplus of 0.4%), and has grown spending 6.4% a year (peers: grown spending 4.1% a year).
In fiscal year 2025 it reported $1,385,003 in revenue and $1,812,108 in expenses, with contributions making up 99.8% of revenue.
The National Pancreas Foundation provides hope for those suffering from pancreatitis and pancreatic cancer through funding cutting edge research, advocating for new and better therapies, and providing support and education for patients, caregivers, and healthcare professionals.
Largest programs · fiscal year 2025
Educational programs including a symposium for renowned specialists to educate on cutting edge research and share insight into pancreatic cancer and acute pancreatitis, an animated module to provide visual formats of learning for patients to improve their understanding of the disease, make informed decisions, and partner with their health-care professionals for optimal outcomes, patient-focused dr… Read more
Educational programs including a symposium for renowned specialists to educate on cutting edge research and share insight into pancreatic cancer and acute pancreatitis, an animated module to provide visual formats of learning for patients to improve their understanding of the disease, make informed decisions, and partner with their health-care professionals for optimal outcomes, patient-focused drug development process, and a national patient registry that serves as valuable resource to understand effectiveness of treatments, and quality of life of patients affected by pancreatic conditions.
$335,124 spent · 22.6% of program spending
Grants were issued to initiate and foster the pursuit of medical advancements in pancreatic disease research.$94,146 spent · 6.3% of program spending
Programs and events held by national and state chapters to further enhance the outreach to patients suffering from these diseases through various opportunities to promote education and awareness.$290,960 spent · 19.6% of program spending
Where each dollar went · fiscal year 2025
Of every dollar it spent, 82¢ went to programs, 11¢ to management and 7¢ to fundraising.
Programs $1,483,280
Management $206,392
Fundraising $122,436
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
82%
Meets
Compared with Bethesda peers
Measure
This organization
Peer median
Operating reserves
0.6 mo
3.5 mo
Typical margin
−14.9%
+0.4%
Spending growth
+6.4% / yr
+4.1% / yr
Debt load
82.7%
18.4%
Peers: the 7 Bethesda medical research organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$1,385,003Fiscal year 2025
Expenses$1,812,108Fiscal year 2025
Total assets$498,895Fiscal year 2025
Total liabilities$412,763Fiscal year 2025
Fiscal year ending March2025
Revenue$1,385,003
Expenses$1,812,108
Net income−$427,105
Net assets$86,132
Notable sources of revenue
Percent of total revenue
Contributions
$1,382,291
99.8%
Program services
$0
0.0%
Investment income
$2,282
0.2%
Other (net)
$430
0.0%
Assets / debt
Total assets
$498,895
Total liabilities
$412,763
Net assets
$86,132
Compensation
Not in our extract for this year.
Fiscal year ending March2024
Revenue$1,353,781
Expenses$1,942,059
Net income−$588,278
Net assets$513,237
Notable sources of revenue
Percent of total revenue
Contributions
$1,343,376
99.2%
Program services
$0
0.0%
Investment income
$10,405
0.8%
Other (net)
$0
0.0%
Assets / debt
Total assets
$623,372
Total liabilities
$110,135
Net assets
$513,237
Compensation
Not in our extract for this year.
Fiscal year ending March2023
Revenue$2,721,582
Expenses$2,153,551
Net income$568,031
Net assets$1,101,515
Notable sources of revenue
Percent of total revenue
Contributions
$2,710,264
99.6%
Program services
$0
0.0%
Investment income
$29
0.0%
Other (net)
$11,289
0.4%
Assets / debt
Total assets
$1,911,190
Total liabilities
$809,675
Net assets
$1,101,515
Compensation
Not in our extract for this year.
Fiscal year ending March2022
Revenue$1,408,995
Expenses$1,503,430
Net income−$94,435
Net assets$533,484
Notable sources of revenue
Percent of total revenue
Contributions
$605,725
43.0%
Program services
$0
0.0%
Investment income
$17
0.0%
Other (net)
$803,253
57.0%
Assets / debt
Total assets
$811,635
Total liabilities
$278,151
Net assets
$533,484
Compensation
Officers and key employees
$242,182
Share of expenses
16.1%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?